The portfolio maintains a cost advantage over competitors, priced within the second-cheapest fee quintile among peers.
Goldman Sachs Future Health Care Eq ETF GDOC
Morningstar’s Analysis GDOC
Will GDOC outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 53.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 10.60 | 2.8 Mil | Healthcare |
AstraZeneca PLC | 6.19 | 1.6 Mil | Healthcare |
Novo Nordisk A/S Class B | 5.86 | 1.5 Mil | Healthcare |
Boston Scientific Corp | 5.80 | 1.5 Mil | Healthcare |
Intuitive Surgical Inc | 4.92 | 1.3 Mil | Healthcare |
AbbVie Inc | 4.58 | 1.2 Mil | Healthcare |
Amgen Inc | 4.54 | 1.2 Mil | Healthcare |
Danaher Corp | 3.77 | 988,259 | Healthcare |
Neurocrine Biosciences Inc | 3.35 | 878,645 | Healthcare |
Insulet Corp | 3.31 | 866,404 | Healthcare |